NCT05617885: An ongoing trial by Praful Ravi, MB BCHir, MRCP
This trial is ongoing. It must report results 7 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05617885 |
|---|---|
| Title | A Phase 1/2 Study of Darolutamide and Abemaciclib in High-Risk Prostate Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 9, 2023 |
| Completion date | July 15, 2025 |
| Required reporting date | July 15, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |